Cardiology Devices - Indonesia | Statista Market Forecast

The projected revenue in the Cardiology Devices market market in Indonesia is estimated to reach US$324.10m by 2024.
It is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 8.94%, leading to a market volume of US$497.40m by 2029.
When compared globally, the United States is anticipated to generate the highest revenue of US$25.77bn in 2024.
Indonesia's growing healthcare infrastructure and increasing disposable income are driving demand for advanced cardiology devices in the country.

Definition:
The Cardiology Devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.

Cardiology diagnostic & monitoring devices
Cardiology surgical devices
Implants such as pacemakers

Cardiology drugs
Cardiology supplements

The Cardiology Devices market in Indonesia has been experiencing significant growth in recent years due to several key factors.

Customer preferences: Indonesian customers have shown a growing preference for advanced cardiology devices that offer innovative features and improved patient outcomes. They are increasingly seeking devices that are minimally invasive, provide accurate diagnostics, and offer effective treatment options. This preference for advanced technology is driving the demand for cutting-edge cardiology devices in the market.

Trends in the market: One of the key trends in the cardiology devices market in Indonesia is the increasing adoption of interventional cardiology procedures. This includes procedures such as angioplasty and stenting, which are minimally invasive and offer faster recovery times for patients. The demand for devices used in these procedures, such as coronary stents and catheters, has been steadily rising as healthcare providers in Indonesia invest in the necessary infrastructure and training to perform these procedures. Another trend in the market is the growing prevalence of cardiovascular diseases in Indonesia. Factors such as sedentary lifestyles, unhealthy diets, and an aging population contribute to the high incidence of heart-related conditions in the country. This has led to an increased demand for cardiology devices for both diagnostic and treatment purposes.

Local special circumstances: Indonesia is the largest country in Southeast Asia, with a population of over 270 million people. The country's large population, combined with the increasing prevalence of cardiovascular diseases, presents a significant market opportunity for cardiology device manufacturers. Moreover, the Indonesian government has been investing in the development of healthcare infrastructure, including the establishment of new hospitals and clinics, which further contributes to the growth of the cardiology devices market.

Underlying macroeconomic factors: Indonesia has been experiencing steady economic growth in recent years, which has led to an increase in disposable income and improved access to healthcare services. As a result, more Indonesians are able to afford advanced cardiology devices and treatments, driving the demand in the market. In conclusion, the Cardiology Devices market in Indonesia is experiencing significant growth due to customer preferences for advanced technology, the increasing adoption of interventional cardiology procedures, the growing prevalence of cardiovascular diseases, the country's large population, and the steady economic growth. These factors create a favorable environment for the expansion of the cardiology devices market in Indonesia.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.